Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Kezang Tshering, Naeti Suksomboon, Montarat Thavorncharoensap & Nalinee Poolsup. (2021) Prevalence and factors associated with depression among adult HIV patients attending ART clinics: a cross-sectional study in Western Bhutan. AIDS Care 33:9, pages 1139-1145.
Read now
Read now
Mary Clare Masters, Karen M. Krueger, Janna L. Williams, Lindsay Morrison & Susan E. Cohn. (2019) Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States. Expert Review of Clinical Pharmacology 12:12, pages 1129-1143.
Read now
Read now
Monika dos Santos. (2015) Cognition and coping functions in people living with HIV. Journal of Psychology in Africa 25:4, pages 327-334.
Read now
Read now
Jeanne Sibiude, Josiane Warszawski & Stéphane Blanche. (2015) Tolerance of the newborn to antiretroviral drug exposure in utero. Expert Opinion on Drug Safety 14:5, pages 643-654.
Read now
Read now
Anthony M. Mills, Calvin Cohen, Edwin DeJesus, Cynthia Brinson, Scott Williams, Kitty L. Yale, Srini Ramanathan, Maggie H. Wang, Kirsten White, Susan K. Chuck & Andrew K. Cheng. (2013) Efficacy and Safety 48 Weeks after Switching from Efavirenz to Rilpivirine Using Emtricitabine/Tenofovir Disoproxil Fumarate–Based Single-Tablet Regimens. HIV Clinical Trials 14:5, pages 216-223.
Read now
Read now
Fatemeh Dabaghzadeh, Hossein Khalili, Padideh Ghaeli & Simin Dashti-Khavidaki. (2012) Potential benefits of cyproheptadine in HIV-positive patients under treatment with antiretroviral drugs including efavirenz. Expert Opinion on Pharmacotherapy 13:18, pages 2613-2624.
Read now
Read now
Paul Flowers, Mark
McGregor Davis, Michael Larkin, Stephanie Church & Claire Marriott. (2011) Understanding the impact of HIV diagnosis amongst gay men in Scotland: An interpretative phenomenological analysis. Psychology & Health 26:10, pages 1378-1391.
Read now
Read now
Mona Arab-Alameddine, Laurent Arhtur Décosterd, Thierry Buclin, Amalio Telenti & Chantal Csajka. (2011) Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics. Expert Opinion on Drug Metabolism & Toxicology 7:5, pages 609-622.
Read now
Read now
Peng Zhan & Xinyong Liu. (2011) Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 – 2010). Expert Opinion on Therapeutic Patents 21:5, pages 717-796.
Read now
Read now
G. I. T. Cavalcante, V. L. M. Capistrano$suffix/text()$suffix/text(), F. S. D. Cavalcante, S. M. M. Vasconcelos, D. S. Macêdo, F. C. F. Sousa, D. J. Woods & M. M. F. Fonteles. (2010) Implications of Efavirenz for Neuropsychiatry: A Review. International Journal of Neuroscience 120:12, pages 739-745.
Read now
Read now
Boris Julg & Johannes R Bogner. (2008) Atripla™ – HIV therapy in one pill. Therapeutics and Clinical Risk Management 4:3, pages 573-577.
Read now
Read now
Fabienne Marcellin, Raoul Moh, Maria Patrizia Carrieri, Christine Danel, Camelia Protopopescu, Delphine Gabillard, Bruno Spire & Xavier Anglaret. (2008) Depressive Symptoms and Exposure to Efavirenz in West African HIV-Infected Adults. HIV Clinical Trials 9:6, pages 445-447.
Read now
Read now
Articles from other publishers (62)
Linda-Gail Bekker, Chris Beyrer, Nyaradzo Mgodi, Sharon R. Lewin, Sinead Delany-Moretlwe, Babafemi Taiwo, Mary Clare Masters & Jeffrey V. Lazarus. (2023) HIV infection. Nature Reviews Disease Primers 9:1.
Crossref
Crossref
Ameet Dravid, Anant S. Pilawan, Anuradha S.Dnyanesh N. Morkar, John T Ramapuram, Kulkarni Milind Madhukarrao, K. Sunil Naik, Milind Bhrusundi, Raveendra K. R, Siddabathuni Nageswaramma & Vinay Kulkarni. (2022) Efficacy and safety of 400 mg efavirenz versus standard 600 mg dose when taken with tenofovir and lamivudine combination in Indian adult patients with HIV-1 infection: An open-label, interventional, randomized, non-inferiority trial. Medicine 101:48, pages e31982.
Crossref
Crossref
Xue Chen, Wei Ding, Xiao Cui, Jiaqi Wei, Yang Zhang, Xin Zhang, Tong Zhang & Yulin Zhang. (2022) HIV protease inhibitor attenuated astrocyte autophagy involvement in inflammation via p38 MAPK pathway. Antiviral Research 208, pages 105463.
Crossref
Crossref
Steven Y. Hong, Anna Winston, Nicholus Mutenda, Ndapewa Hamunime, Tuhin Roy, Christine Wanke, Alice M. Tang & Michael R. Jordan. (2022) Predictors of loss to follow-up from HIV antiretroviral therapy in Namibia. PLOS ONE 17:4, pages e0266438.
Crossref
Crossref
Rui Luo, Vincent M. B. Silenzio, Yunxiang Huang, Xi Chen & Dan Luo. (2021) The Changes and the Predictors of Suicidal Ideation Among HIV-positive Sexual Minority Men: A Five-year Longitudinal Study from China. AIDS and Behavior 26:2, pages 339-349.
Crossref
Crossref
Mary Ann Adler Cohen, Danielle Wilkin, Mark V. Bradley, Luis F. Pereira, Kelly L. Cozza & Christina M. Patel. 2022. HIV Psychiatry. HIV Psychiatry
67
91
.
Esteban Martínez. (2021) CNS Considerations in ART Simplification Strategies. Current HIV/AIDS Reports 18:6, pages 549-557.
Crossref
Crossref
Tessa Senneker & Alice Tseng. (2021) An update on neuropsychiatric adverse effects with second-generation integrase inhibitors and nonnucleoside reverse transcriptase inhibitors. Current Opinion in HIV and AIDS 16:6, pages 309-320.
Crossref
Crossref
Ngah Kuan Chow, Sabariah Noor Harun, E‐Jinq Wong, Lee Lee Low, Siti Maisharah Sheikh Ghadzi & Amer Hayat Khan. (2021) The association between cigarette smoking and efavirenz plasma concentration using the population pharmacokinetic approach. British Journal of Clinical Pharmacology 87:10, pages 3756-3765.
Crossref
Crossref
Wangu Masenga, Giacomo Maria Paganotti, Kaelo Seatla, Simani Gaseitsiwe & Kwenga Sichilongo. (2021) A fast-screening dispersive liquid–liquid microextraction–gas chromatography–mass spectrometry method applied to the determination of efavirenz in human plasma samples. Analytical and Bioanalytical Chemistry 413:25, pages 6401-6412.
Crossref
Crossref
Edwin Coleridge S. Naidu, Samuel Oluwaseun Olojede, Sodiq Kolawole Lawal, Carmen Olivia Rennie & Onyemaechi Okpara Azu. (2021) Nanoparticle delivery system, highly active antiretroviral therapy, and testicular morphology: The role of stereology. Pharmacology Research & Perspectives 9:3.
Crossref
Crossref
Tyler Lanman, Scott Letendre, Qing Ma, Anne Bang & Ronald Ellis. (2019) CNS Neurotoxicity of Antiretrovirals. Journal of Neuroimmune Pharmacology 16:1, pages 130-143.
Crossref
Crossref
Madison K. Bangert & Rodrigo Hasbun. 2021. Neurological Complications of Infectious Diseases. Neurological Complications of Infectious Diseases
37
80
.
Edoardo Spina, Maria Antonietta Barbieri, Giuseppe Cicala & Jose de Leon. (2020) Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents. Pharmaceuticals 13:12, pages 439.
Crossref
Crossref
Youdiil Ophinni, Adrian, Kristiana Siste, Martina Wiwie, Gina Anindyajati, Enjeline Hanafi, Reza Damayanti & Yoshitake Hayashi. (2020) Suicidal ideation, psychopathology and associated factors among HIV-infected adults in Indonesia. BMC Psychiatry 20:1.
Crossref
Crossref
Jean B. Ngilirabanga, Paulo P. Rosa, Marique Aucamp, Yunus Kippie & Halima Samsodien. (2020) Dual-drug co-crystal synthesis for synergistic in vitro effect of three key first-line antiretroviral drugs. Journal of Drug Delivery Science and Technology 60, pages 101958.
Crossref
Crossref
Charlotte S. Hakkers, Anne Marie Hermans, Erik M. van Maarseveen, Charlotte E. Teunissen, Inge M. W. Verberk, Joop E. Arends & Andy I. M. Hoepelman. (2020) High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patients. Journal of NeuroVirology 26:4, pages 572-580.
Crossref
Crossref
Mei Tan, Megan Bowers, Phil Thuma & Elena L. Grigorenko. (2020) The Pharmacogenetics of Efavirenz Metabolism in Children: The Potential Genetic and Medical Contributions to Child Development in the Context of Long‐Term ARV Treatment. New Directions for Child and Adolescent Development 2020:171, pages 107-133.
Crossref
Crossref
Madison K. Bangert & Rodrigo Hasbun. (2019) Neurological and Psychiatric Adverse Effects of Antimicrobials. CNS Drugs 33:8, pages 727-753.
Crossref
Crossref
Sphamandla Ntshangase, Sipho Mdanda, Tricia Naicker, Hendrik G. Kruger, Thavendran Govender & Sooraj Baijnath. (2019) Rilpivirine as a potential candidate for the treatment of HIV-associated neurocognitive disorders (HAND). Journal of Molecular Histology 50:4, pages 295-303.
Crossref
Crossref
Kellie J. Goodlet, Monika T. Zmarlicka & Alyssa M. Peckham. (2018) Drug–drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs. CNS Spectrums 24:03, pages 287-312.
Crossref
Crossref
Charlotte S. Hakkers, Joop E. Arends, Guido E. van den Berk, Monique H. M. Ensing, Imke Hooijenga, Matthijs Vink, Martine J. E. van Zandvoort & Andy I. M. Hoepelman. (2019) Objective and Subjective Improvement of Cognition After Discontinuing Efavirenz in Asymptomatic Patients: A Randomized Controlled Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes 80:1, pages e14-e22.
Crossref
Crossref
David F. Tate, Robert H. Paul, Kinga Kertesz, Jared Conley & Troy Russell. 2019. Handbook of Medical Neuropsychology. Handbook of Medical Neuropsychology
485
512
.
Sabina Mugusi, Eliford Ngaimisi, Mohammed Janabi, Ferdinand Mugusi, Omary Minzi, Eric Aris, Muhammad Bakari, Leif Bertilsson, Juergen Burhenne, Eric Sandstrom & Eleni Aklillu. (2018) Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin. European Journal of Clinical Pharmacology 74:11, pages 1405-1415.
Crossref
Crossref
Razia Gaida, Ilse Truter & Christoffel Grobler. (2018) Perspectives of healthcare professionals of the neuropsychiatric side effects associated with efavirenz and its management. Health SA Gesondheid 23.
Crossref
Crossref
Nadezda Apostolova, Ana Blas-Garcia, Maria J. Galindo & Juan V. Esplugues. (2017) Efavirenz: What is known about the cellular mechanisms responsible for its adverse effects. European Journal of Pharmacology 812, pages 163-173.
Crossref
Crossref
Renqi Huang, Zhenglan Chen, Sean Dolan, John A. Schetz & Glenn H. Dillon. (2017) The dual modulatory effects of efavirenz on GABA A receptors are mediated via two distinct sites. Neuropharmacology 121, pages 167-178.
Crossref
Crossref
Razia Gaida, Ilse Truter & Christoffel Grobler. (2016) Incidence of neuropsychiatric side effects of efavirenz in HIV-positive treatment-naïve patients in public-sector clinics in the Eastern Cape. Southern African Journal of HIV Medicine 17:1.
Crossref
Crossref
Fred S. Sarfo, Maame A. Sarfo & David Chadwick. (2016) Incidence and risk factors for neuropsychiatric events among Ghanaian HIV patients on long-term non-nucleoside reverse transcriptase inhibitor-based therapy. eNeurologicalSci 3, pages 21-25.
Crossref
Crossref
Ella T. Nkhoma, John Coumbis, Amanda M. Farr, Stephen S. Johnston, Bong Chul Chu, Lisa C. Rosenblatt, Daniel Seekins & Angelina Villasis-Keever. (2016) No Evidence of an Association Between Efavirenz Exposure and Suicidality Among HIV Patients Initiating Antiretroviral Therapy in a Retrospective Cohort Study of Real World Data. Medicine 95:3, pages e2480.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
25
31
.
Marloes A.M. Janssen, Olga Meulenbroek, Stefan C.A. Steens, Bozena Góraj, Marjolein Bosch, Peter P. Koopmans & Roy P.C. Kessels. (2015) Cognitive functioning, wellbeing and brain correlates in HIV-1 infected patients on long-term combination antiretroviral therapy. AIDS 29:16, pages 2139-2148.
Crossref
Crossref
Haryes A. Funes, Ana Blas-Garcia, Juan V. Esplugues & Nadezda Apostolova. (2015) Efavirenz alters mitochondrial respiratory function in cultured neuron and glial cell lines. Journal of Antimicrobial Chemotherapy 70:8, pages 2249-2254.
Crossref
Crossref
Marie Helleberg, Marianne G Pedersen, Carsten B Pedersen, Preben B Mortensen & Niels Obel. (2015) Associations between HIV and schizophrenia and their effect on HIV treatment outcomes: a nationwide population-based cohort study in Denmark. The Lancet HIV 2:8, pages e344-e350.
Crossref
Crossref
Jonathan E. Kaplan, Kenneth Dominguez, Kebba Jobarteh & Thomas J. Spira. (2015) Postexposure Prophylaxis Against Human Immunodeficiency Virus (HIV): New Guidelines From the WHO: A Perspective. Clinical Infectious Diseases 60:suppl_3, pages S196-S199.
Crossref
Crossref
Glen P. Davis, Hilary L. Surratt, Frances R. Levin & Carlos Blanco. (2014) Antiretroviral medication: An emerging category of prescription drug misuse. The American Journal on Addictions 23:6, pages 519-525.
Crossref
Crossref
Maria Ferrara, Anya Umlauf, Chelsea Sanders, Jonathan M. Meyer, John Allen McCutchan, Nichole Duarte, Joseph Hampton Atkinson, Igor Grant & Ronald J. Ellis. (2014) The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk. Psychiatry Research 218:1-2, pages 201-208.
Crossref
Crossref
Hugo Martins de Oliveira, Adriani Paganini Damiani, Renata de Oliveira Dias, Pedro R.T. Romão & Vanessa M. Andrade. (2014) Effect of antiretroviral drugs on the DNA damage in mice. Environmental Toxicology and Pharmacology 37:1, pages 390-395.
Crossref
Crossref
Peng Zhan, Xuwang Chen, Dongyue Li, Zengjun Fang, Erik De Clercq & Xinyong Liu. (2013) HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design. Medicinal Research Reviews 33:S1, pages E1-E72.
Crossref
Crossref
Fatemeh DabaghzadehPadideh GhaeliHossein KhaliliAbbas AlimadadiSirous JafariShahin AkhondzadehZahra Khazaeipour. (2013) Cyproheptadine for Prevention of Neuropsychiatric Adverse Effects of Efavirenz: A Randomized Clinical Trial. AIDS Patient Care and STDs 27:3, pages 146-154.
Crossref
Crossref
Katherine Kovalski Busby, Sarah Lytle & Martha Sajatovic. 2013. Mental Health Practitioner's Guide to HIV/AIDS. Mental Health Practitioner's Guide to HIV/AIDS
9
35
.
Caroline Parker. (2012) Psychiatric effects of drugs for other disorders. Medicine 40:12, pages 691-695.
Crossref
Crossref
F Kaestner, K Anneken, C Mostert, D Reichelt, M Rothermundt, S Evers & I W Husstedt. (2012) Depression associated with antiretroviral drug therapy in HIV: case report and overview. International Journal of STD & AIDS 23:6, pages e14-e19.
Crossref
Crossref
R. Navinés, J. Blanch, A. Rousaud, J. Moreno-España & R. Martín-Santos. (2012) A non-affective psychotic syndrome after starting antiretroviral therapy. Revista Brasileira de Psiquiatria 34:2, pages 226-229.
Crossref
Crossref
Crystal C. Watkins, Andrew A. Pieper & Glenn J. Treisman. (2011) Safety Considerations in Drug Treatment of Depression in HIV-Positive Patients. Drug Safety 34:8, pages 623-639.
Crossref
Crossref
Arvind Venkat & Sukhjit S. Takhar. 2011. Challenging and Emerging Conditions in Emergency Medicine. Challenging and Emerging Conditions in Emergency Medicine
141
157
.
Pedro R. T. Romão, Joelson C. Lemos, Jeverson Moreira, Gisele de Chaves, Morgana Moretti, Adalberto A. Castro, Vanessa M. Andrade, Carina R. Boeck, João Quevedo & Elaine C. Gavioli. (2009) Anti-HIV Drugs Nevirapine and Efavirenz Affect Anxiety-Related Behavior and Cognitive Performance in Mice. Neurotoxicity Research 19:1, pages 73-80.
Crossref
Crossref
Mazhar H. Golewale, Matthew Macaluso & Ahsan Y. Khan. (2010) A 44-year-old Black Man with Delusions. Psychiatric Annals 40:5, pages 249-251.
Crossref
Crossref
Mazhar H. Golewale, Matthew Macaluso & Ahsan Y. Khan. (2010) A 44-Year-Old Black Man with Delusions. Psychiatric Annals 40:5, pages 249-251.
Crossref
Crossref
Tami BentonJoshua Blume & Benoit Dubé. (2010) Treatment considerations for psychiatric syndromes associated with HIV infection. HIV Therapy 4:2, pages 231-245.
Crossref
Crossref
Michael L. Mitchell, Jong Chan Son, Ill Young Lee, Chong-Kyo Lee, Hae Soo Kim, Hongyan Guo, Jianhong Wang, Jaclyn Hayes, Michael Wang, Amber Paul, Eric B. Lansdon, James M. Chen, Gene Eisenberg, Romas Geleziunas, Lianhong Xu & Choung U. Kim. (2010) N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic & Medicinal Chemistry Letters 20:5, pages 1585-1588.
Crossref
Crossref
Michael L. Mitchell, Jong Chan Son, Hongyan Guo, Yun-A Im, Eun Jung Cho, Jianhong Wang, Jaclyn Hayes, Michael Wang, Amber Paul, Eric B. Lansdon, James M. Chen, Doris Graupe, Gerry Rhodes, Gong-Xin He, Romas Geleziunas, Lianhong Xu & Choung U. Kim. (2010) N1-Alkyl pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic & Medicinal Chemistry Letters 20:5, pages 1589-1592.
Crossref
Crossref
Oliver Koch, Susanne Sheehy, Catherine Sargent, Jane Democratis, Sarah Abbas, Jurgen Schiefermueller & Brian J. Angus. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions
529
553
.
David F. Tate, Robert H. Paul, Kinga Kertesz, Jared Conley & Troy Russell. 2010. Handbook of Medical Neuropsychology. Handbook of Medical Neuropsychology
373
396
.
F. Maggiolo. (2009) Efavirenz: a decade of clinical experience in the treatment of HIV. Journal of Antimicrobial Chemotherapy 64:5, pages 910-928.
Crossref
Crossref
Kelly Brogan & Joseph Lux. (2009) Management of common psychiatric conditions in the HIV-positive population. Current HIV/AIDS Reports 6:2, pages 108-115.
Crossref
Crossref
Katherine M Coyne, Anton L Pozniak, Mohammed Lamorde & Marta Boffito. (2009) Pharmacology of second-line antituberculosis drugs and potential for interactions with antiretroviral agents. AIDS 23:4, pages 437-446.
Crossref
Crossref
Ron Cohen. 2009. HIV and the Brain. HIV and the Brain
133
186
.
Emilio L. Streck, Giselli Scaini, Gislaine T. Rezin, Jeverson Moreira, Celine M. Fochesato & Pedro R. T. Romão. (2008) Effects of the HIV treatment drugs nevirapine and efavirenz on brain creatine kinase activity. Metabolic Brain Disease 23:4, pages 485-492.
Crossref
Crossref
Arvind Venkat, David M. Piontkowsky, Robert R. Cooney, Adarsh K. Srivastava, Gregory A. Suares & Cory P. Heidelberger. (2008) Care of the HIV-Positive Patient in the Emergency Department in the Era of Highly Active Antiretroviral Therapy. Annals of Emergency Medicine 52:3, pages 274-285.
Crossref
Crossref
J. D. Hartzell, I. E. Janke & A. C. Weintrob. (2008) Impact of depression on HIV outcomes in the HAART era. Journal of Antimicrobial Chemotherapy 62:2, pages 246-255.
Crossref
Crossref
Andrew P RiceRichard E Sutton. (2007) Targeting protein–protein interactions for HIV therapeutics. Future HIV Therapy 1:4, pages 369-385.
Crossref
Crossref